The Development of Diagnostic Biomarker Panels for Hepatitis and Liver Cancer

Strategic Alliance for The Development of Diagnostic Biomarker Panels for Hepatitis and Liver Cancer

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01310062

Enrollment

1600

Registered

2011-03-07

Start date

2010-08-31

Completion date

2012-08-31

Last updated

2011-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carcinoma,Hepatocellular, Hepatitis B,Chronic

Keywords

hepatocellular carcinoma, microarray, gene expression profiling, biomarkers

Brief summary

More recent studies have shown that the HBV-infected population has a greater risk of development of hepatocellular carcinoma. Nevertheless, there are still a significant number of people chronically infected by HBV who do not develop the complication. Hence, there exist biological markers that could be indicator for the disease-inducing and carcinogenic potential of the virus.

Interventions

None listed

Study design

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

21 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Patients of at least 21 years old on day of giving consent for study * Patients must be able and wiling to give an informed consent * Patient with chronic HBV infection * Patient with active hepatocellular carcinoma and chronic hepatitis B * Healthy subjects

Exclusion criteria

* Patients who have co-infection with HIV or chronic hepatitis C * Subjects with other types of cancer

Countries

Malaysia

Contacts

Primary ContactClinical Research Centre

shanthini@crc.gov.my+603-40439300

Outcome results